OPTIMER PHARMACEUTICALS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 19 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-12-05: Reporting owner Che Tessie M; Form 4; Security Stock option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-12-05: Reporting owner Chang Michael N; Form 4; Security Stock option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-05-27: Reporting owner LICHTINGER PEDRO; Form 4; Security Stock option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-05-27: Reporting owner Che Tessie M; Form 4; Security Stock option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-12-05 | Che Tessie M Officer (COO and SVP) | 4 | Stock option (right to buy) Derivative · Indirect · by spouse | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $12.34 exercise price | 2011-12-12 | |
| 2011-12-05 | Chang Michael N Director | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $12.34 exercise price | 2011-12-12 | |
| 2011-05-27 | LICHTINGER PEDRO Director, Officer (CEO and President) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $12.34 exercise price | 2011-06-01 | |
| 2011-05-27 | Che Tessie M Officer (COO and SVP) | 4 | Stock option (right to buy) Derivative · Indirect · by spouse | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $12.34 exercise price | 2011-06-01 | |
| 2011-05-27 | Chang Michael N Director | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $12.34 exercise price | 2011-06-01 | |
| 2011-04-25 | Che Tessie M Officer (COO and SVP) | 4 | Stock option (right to buy) Derivative · Indirect · by spouse | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100,000 117,263 owned after | $1.08 exercise price | 2011-04-27 | |
| 2011-04-25 | Chang Michael N Director | 4 | Stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +100,000 117,263 owned after | $1.08 exercise price | 2011-04-27 | |
| 2011-02-02 | LICHTINGER PEDRO Director, Officer (President and CEO) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $12.34 exercise price | 2011-03-22 | |
| 2011-01-26 | Shue Youe Kong Officer (VP, Clinical Dev't) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $11.41 exercise price | 2011-01-27 | |
| 2011-01-26 | Chang Michael N Director | 4 | Stock option (right to buy) Derivative · Indirect · by spouse | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $11.41 exercise price | 2011-01-27 | |
| 2011-01-26 | Che Tessie M Officer (COO and SVP) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $11.41 exercise price | 2011-01-27 | |
| 2011-01-26 | AMPER LINDA E Officer (SVP, Human Resources) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $11.41 exercise price | 2011-01-27 | |
| 2011-01-26 | Prunty John D Officer (CFO and VP, Finance) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $11.41 exercise price | 2011-01-27 | |
| 2011-01-26 | LICHTINGER PEDRO Director, Officer (CEO and President) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,000 58,000 owned after | $11.41 exercise price | 2011-01-27 | |
| 2011-01-21 | Che Tessie M Officer (COO and SVP) | 4 | Stock option (right to buy) Derivative · Indirect · by spoouse | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $12.34 exercise price | 2011-01-25 | |
| 2011-01-21 | Chang Michael N Director | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $12.34 exercise price | 2011-01-25 | |
| 2011-01-10 | MCKINNELL HENRY A Director | 4 | Stock option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $11.67 exercise price | 2011-01-11 | |
| 2011-01-10 | MCKINNELL HENRY A Director | 4 | Stock option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $11.67 exercise price | 2011-01-11 | |
| 2011-01-03 | Papaz Gregory E. Officer (SVP, Commercial Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $11.42 exercise price | 2011-01-20 |